Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (191-200 of 302) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|November 10, 2012
The impact of close surgical margins after radical hysterectomy for early-stage cervical cancerGeorgia A McCann, Susanne K Taege, Christina E Boutsicaris, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 12, 2020
Corrigendum to "Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy" [Mater Sci Eng C 102 (2019) 113-123]Pankaj Dwivedi, Shuya Han, Farhana Mangrio, et al.
Frontiers in Genetics|September 15, 2025
Identification of oncofetal PIWI-interacting RNAs as potential prognostic biomarkers in non-small cell lung cancerMichelle E Pewarchuk, Vanessa G P Souza, David E Cohn, et al.
Materials Science & Engineering. C, Materials for Biological Applications|June 1, 2019
Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapyPankaj Dwivedi, Shuya Han, Farhana Mangrio, et al.
Gynecologic Oncology|July 10, 2026
Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?Paulina J Haight, Julia C Sakach, Laura M Chambers, et al.
Gynecologic Oncology|August 28, 2023
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?Molly Morton, Eric M McLaughlin, Corinne A Calo, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
The American Journal of Clinical Nutrition|March 6, 2015
Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health InitiativeTheodore M Brasky, Rebecca J Rodabough, Jingmin Liu, et al.
Gynecologic Oncology|May 13, 2023
Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubblesMeghan M Newcomer, Kalpana Deepa Priya Dorayappan, Vincent Wagner, et al.
Psycho-Oncology|April 9, 2025
Combined Treatment With Cognitive Behavioral Therapy for Insomnia and Acceptance and Commitment Therapy Enhances Objective and Subjective Reports of Sleep in Patients With Advanced CancerSharla Wells-Di Gregorio, Stacy Flowers, Juan Peng, et al.
Pageof 31

Showing results (191-200 of 302) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|November 10, 2012
The impact of close surgical margins after radical hysterectomy for early-stage cervical cancerGeorgia A McCann, Susanne K Taege, Christina E Boutsicaris, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 12, 2020
Corrigendum to "Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy" [Mater Sci Eng C 102 (2019) 113-123]Pankaj Dwivedi, Shuya Han, Farhana Mangrio, et al.
Frontiers in Genetics|September 15, 2025
Identification of oncofetal PIWI-interacting RNAs as potential prognostic biomarkers in non-small cell lung cancerMichelle E Pewarchuk, Vanessa G P Souza, David E Cohn, et al.
Materials Science & Engineering. C, Materials for Biological Applications|June 1, 2019
Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapyPankaj Dwivedi, Shuya Han, Farhana Mangrio, et al.
Gynecologic Oncology|July 10, 2026
Response to mirvetuximab soravtansine and weekly paclitaxel based on treatment sequencing in platinum-resistant ovarian cancer: Does order matter?Paulina J Haight, Julia C Sakach, Laura M Chambers, et al.
Gynecologic Oncology|August 28, 2023
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?Molly Morton, Eric M McLaughlin, Corinne A Calo, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
The American Journal of Clinical Nutrition|March 6, 2015
Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health InitiativeTheodore M Brasky, Rebecca J Rodabough, Jingmin Liu, et al.
Gynecologic Oncology|May 13, 2023
Tissue factor as a novel diagnostic target for early detection of ovarian cancer using ultrasound microbubblesMeghan M Newcomer, Kalpana Deepa Priya Dorayappan, Vincent Wagner, et al.
Psycho-Oncology|April 9, 2025
Combined Treatment With Cognitive Behavioral Therapy for Insomnia and Acceptance and Commitment Therapy Enhances Objective and Subjective Reports of Sleep in Patients With Advanced CancerSharla Wells-Di Gregorio, Stacy Flowers, Juan Peng, et al.
Pageof 31